Advertisement
Emer Cooke said Tuesday that the agency is “firmly convinced” that the benefits of the AstraZeneca shot outweigh the risks, but an evaluation is ongoing.
Cooke said experts are meeting this week to discuss the available information and will make a recommendation Thursday.